Day One Biopharmaceuticals(@DayOneBio) 's Twitter Profileg
Day One Biopharmaceuticals

@DayOneBio

We are a new biotech company focused on developing new cancer therapies for patients of all ages.

ID:1059104071922020353

linkhttp://www.dayonebio.com calendar_today04-11-2018 15:24:22

323 Tweets

983 Followers

234 Following

Day One Biopharmaceuticals(@DayOneBio) 's Twitter Profile Photo

This past weekend, some of our Denver-based Day One team members came together to participate in the local 2nd Annual Tumor Trot. Supporting the fight against childhood brain tumors is a cause we deeply believe in.

This past weekend, some of our Denver-based Day One team members came together to participate in the local 2nd Annual Tumor Trot. Supporting the fight against childhood brain tumors is a cause we deeply believe in. #BrainTumorAwareness #BTAM #GoGrayinMay
account_circle
Day One Biopharmaceuticals(@DayOneBio) 's Twitter Profile Photo

Looking forward to the 5th Annual SIOPE 🎗️ Meeting this year! We can't wait to engage with international stakeholders to discuss the current priorities and needs of children with cancer

Looking forward to the 5th Annual @SIOPEurope Meeting this year! We can't wait to engage with international stakeholders to discuss the current priorities and needs of children with cancer #SIOPEurope2024
account_circle
Day One Biopharmaceuticals(@DayOneBio) 's Twitter Profile Photo

Join us on May 15th for Part 2 of our webinar featuring advice on effectively advocating for children with pediatric low-grade glioma ( ). Click bit.ly/4a6C5pA

account_circle
Day One Biopharmaceuticals(@DayOneBio) 's Twitter Profile Photo

Day One's team is looking forward to meeting you at Bicom's Life Science Career Expo on 5/15! We are looking forward to joining leading employers in the industry at this exciting event that includes a job fair and educational sessions for job seekers: bit.ly/3URfSYw

Day One's team is looking forward to meeting you at Bicom's Life Science Career Expo on 5/15! We are looking forward to joining leading employers in the industry at this exciting event that includes a job fair and educational sessions for job seekers: bit.ly/3URfSYw
account_circle
Day One Biopharmaceuticals(@DayOneBio) 's Twitter Profile Photo

Day One is pleased to share our recently published descriptive retrospective cross-sectional pilot study which explored the feasibility of quantifying disease burden and healthcare resource utilization in a cohort of patients with pLGG: bit.ly/3UEoH7G

Day One is pleased to share our recently published descriptive retrospective cross-sectional pilot study which explored the feasibility of quantifying disease burden and healthcare resource utilization in a cohort of patients with pLGG: bit.ly/3UEoH7G
account_circle
Day One Biopharmaceuticals(@DayOneBio) 's Twitter Profile Photo

During , we’re committed to shining a light on the profound impact the disease has on children and their families, and the crucial need for more research, treatment options, and support. Join us in raising awareness as we

account_circle
Day One Biopharmaceuticals(@DayOneBio) 's Twitter Profile Photo

Multistakeholder collaboration is essential to advancing pediatric cancer research. We convened leaders in the field to create a framework that explores the critical roles played by nonprofits, industry, & academia. bit.ly/3UGa3Ns

Multistakeholder collaboration is essential to advancing pediatric cancer research. We convened leaders in the field to create a framework that explores the critical roles played by nonprofits, industry, & academia. bit.ly/3UGa3Ns
account_circle
Day One Biopharmaceuticals(@DayOneBio) 's Twitter Profile Photo

We are proud to share the accelerated approval by the US FDA of the first targeted medicine for the treatment of patients with relapsed or refractory pediatric low-grade glioma ( ) with a BRAF fusion or rearrangement, or BRAF V600 mutation. Learn more: bit.ly/3xNgk0P

We are proud to share the accelerated approval by the US FDA of the first targeted medicine for the treatment of patients with relapsed or refractory pediatric low-grade glioma (#pLGG) with a BRAF fusion or rearrangement, or BRAF V600 mutation. Learn more: bit.ly/3xNgk0P
account_circle
Day One Biopharmaceuticals(@DayOneBio) 's Twitter Profile Photo

This Sunday, tune into our webinar series intended to empower caregivers of children living with . The first session of this two-part webinar will feature Stacia Wagner of Children’s Brain Tumor Foundation and Alistair Robertson of Valley Children’s Healthcare. Register: bit.ly/3vZw7sE

This Sunday, tune into our webinar series intended to empower caregivers of children living with #pLGG. The first session of this two-part webinar will feature Stacia Wagner of @cbtf_org and Alistair Robertson of Valley Children’s Healthcare. Register: bit.ly/3vZw7sE
account_circle
Day One Biopharmaceuticals(@DayOneBio) 's Twitter Profile Photo

Molly’s advice for others going through a pediatric low-grade glioma journey is to keep a list of questions to ask the doctor — even the small things. To hear more stories from people living with & tips for navigating a challenging diagnosis, visit: rethinkplgg.com/patient/person…

account_circle
Day One Biopharmaceuticals(@DayOneBio) 's Twitter Profile Photo

Today, we celebrate and support ! There is a considerable need for increased visibility and awareness for rare diseases which impact 300 million people across the globe.

Today, we celebrate and support #RareDiseaseDay! There is a considerable need for increased visibility and awareness for rare diseases which impact 300 million people across the globe.
account_circle
Day One Biopharmaceuticals(@DayOneBio) 's Twitter Profile Photo

Head of R&D and co-founder Samuel Blackman shares the Day One journey to reshape drug development in this article for the Pediatric Cancer Research Foundation' Profectus blog: bit.ly/3URbMzF

Head of R&D and co-founder Samuel Blackman shares the Day One journey to reshape #pediatriccancer drug development in this article for the @PCRF_Kids' Profectus blog: bit.ly/3URbMzF
account_circle
Day One Biopharmaceuticals(@DayOneBio) 's Twitter Profile Photo

Our Head of R&D, Sam Blackman, recently sat down with Michael Pietrack of the PharmaVerse Podcast to discuss how Sam’s expedition to the base camp of Mount Everest influenced his philosophy. Watch the full episode here: youtube.com/watch?v=h0bsuy…

Our Head of R&D, Sam Blackman, recently sat down with Michael Pietrack of the PharmaVerse Podcast to discuss how Sam’s expedition to the base camp of Mount Everest influenced his #leadership philosophy. Watch the full episode here: youtube.com/watch?v=h0bsuy…
account_circle
Day One Biopharmaceuticals(@DayOneBio) 's Twitter Profile Photo

Today, on , we spotlight the selfless care, love and support s provide to those who need it most. Remember to thank a , not only today, but every day, for helping our loved ones live better lives.

Today, on #NationalCaregiversDay, we spotlight the selfless care, love and support #caregivers provide to those who need it most. Remember to thank a #caregiver, not only today, but every day, for helping our loved ones live better lives.
account_circle
Day One Biopharmaceuticals(@DayOneBio) 's Twitter Profile Photo

We are looking forward to attending the 12th ACCELERATE Paediatric Oncology Annual Conference, where we’ll delve into discussions about the most recent successes in drug development worldwide. Learn more: bit.ly/3SR2CCb

We are looking forward to attending the 12th ACCELERATE Paediatric Oncology Annual Conference, where we’ll delve into discussions about the most recent successes in #pediatriconcology drug development worldwide. Learn more: bit.ly/3SR2CCb
account_circle
Day One Biopharmaceuticals(@DayOneBio) 's Twitter Profile Photo

Today, on , we raise awareness about the urgent need to . Children wait 6.5 years longer than adults for treatment. We are committed to putting children at the forefront of everything we do.

Learn more: bit.ly/3SIdt14

Today, on #WorldCancerDay, we raise awareness about the urgent need to #CloseTheCareGap. Children wait 6.5 years longer than adults for #cancer treatment. We are committed to putting children at the forefront of everything we do. Learn more: bit.ly/3SIdt14
account_circle
Day One Biopharmaceuticals(@DayOneBio) 's Twitter Profile Photo

is a significant and defining moment for families and their healthcare providers. Hear from Dr. Mark Kieran as he highlights the significance of trust, support, and open communication for families navigating a new diagnosis.
thedayonetalk.com

account_circle
Day One Biopharmaceuticals(@DayOneBio) 's Twitter Profile Photo

: Passionate about shaping strategies and fostering organizational effectiveness? We're looking for a Vice President, People Business Partner, to join our team. Learn more: bit.ly/48IkswH

#WereHiring: Passionate about shaping #HR strategies and fostering organizational effectiveness? We're looking for a Vice President, People Business Partner, to join our team. Learn more: bit.ly/48IkswH #Hiring #JoinOurTeam
account_circle
Day One Biopharmaceuticals(@DayOneBio) 's Twitter Profile Photo

We are proud to announce the appointment of Habib Dable and Dr. William Grossman to our Board of Directors. Their extensive expertise in oncology will provide valuable contributions as we navigate the ongoing growth and evolution of our company. bit.ly/3HkTi2y

We are proud to announce the appointment of Habib Dable and Dr. William Grossman to our Board of Directors. Their extensive expertise in oncology will provide valuable contributions as we navigate the ongoing growth and evolution of our company. bit.ly/3HkTi2y
account_circle
Day One Biopharmaceuticals(@DayOneBio) 's Twitter Profile Photo

We’re looking forward to attending ! Our CEO, Dr. Jeremy Bender, will be presenting on Monday, January 8 at 10:30 AM PT. If you’re unable to be there in person, be sure to tune in to the live audio webcast: bit.ly/3NN3Ifd

We’re looking forward to attending #JPM24! Our CEO, Dr. Jeremy Bender, will be presenting on Monday, January 8 at 10:30 AM PT. If you’re unable to be there in person, be sure to tune in to the live audio webcast: bit.ly/3NN3Ifd
account_circle